- Home
- CBU vs ELVN Comparison
CBU vs ELVN Comparison
Compare CBU & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBU | ELVN |
|---|---|---|
| Founded | 1866 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.2B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CBU | ELVN |
|---|---|---|
| Price | $58.55 | $41.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | $69.17 | ★ $73.67 |
| AVG Volume (30 Days) | 261.6K | ★ 1.2M |
| Earning Date | 10-27-2026 | 11-11-2026 |
| Dividend Yield | ★ 3.32% | N/A |
| EPS Growth | ★ 15.41 | 3.17 |
| EPS | ★ 2.24 | N/A |
| Revenue | ★ $818,007,000.00 | N/A |
| Revenue This Year | $9.59 | N/A |
| Revenue Next Year | $7.68 | N/A |
| P/E Ratio | $26.38 | ★ N/A |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $53.46 | $14.79 |
| 52 Week High | $71.11 | $62.32 |
Technical Indicators
Market Signals| Indicator | CBU | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 27.82 | 25.50 |
| Support Level | $56.74 | $38.58 |
| Resistance Level | $58.83 | $43.05 |
| Average True Range (ATR) | 1.05 | 1.91 |
| MACD | -0.13 | -0.41 |
| Stochastic Oscillator | 5.23 | 23.77 |
Price Performance
Historical ComparisonAbout CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional, and governmental customers. The Company also offers comprehensive financial planning, trust administration, and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services, and Wealth Management Services. The group generates the majority of its revenue from the Banking and Corporate segment.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.